SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-19-008423
Filing Date
2019-02-14
Accepted
2019-02-14 09:06:41
Documents
1
Group Members
BROOKSIDE CAPITAL INVESTORS II, L.P.BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a19-4513_1sc13ga.htm SC 13G/A 148662
  Complete submission text file 0001104659-19-008423.txt   150660
Mailing Address C/O BAIN CAPITAL PUBLIC EQUITY, LP 200 CLARENDON STREET BOSTON MA 02116
Business Address C/O BAIN CAPITAL PUBLIC EQUITY, LP 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Public Equity Management, LLC (Filed by) CIK: 0001156175 (see all company filings)

IRS No.: 043517087 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88256 | Film No.: 19601331
SIC: 2834 Pharmaceutical Preparations